Last reviewed · How we verify

NCT07215039

Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida

ENROLLING BY INVITATION Last updated 17 April 2026
What this trial tests

trial testing Survey in Hematopoietic and Lymphatic System Neoplasm in 1,200 participants. Enrolling by invitation.

Timeline
10 November 2025
Primary endpoint
30 October 2027
30 October 2027

Quick facts

Lead sponsorMayo Clinic
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment1,200
Start date10 November 2025
Primary completion30 October 2027
Estimated completion30 October 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, female only, with Hematopoietic and Lymphatic System Neoplasm or Malignant Solid Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates cancer screening awareness, personal and family cancer history, and barriers to screening among incarcerated women at Gadsden Correctional Facility. The information will be used to inform the content of a tailored digital educational module on screenable types of cancer, their risk factors, and current screening guidelines that will be disseminated to US prisons and incorporated into release programs and general health literacy programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

Other recruiting trials for Hematopoietic and Lymphatic System Neoplasm

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07215039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing